Carbohydrate-based therapeutics

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Osborn, H.M.I. orcid id iconORCID: https://orcid.org/0000-0002-0683-0457, Evans, P.G., Gemmell, N. and Osborne, S.D. (2004) Carbohydrate-based therapeutics. Journal of Pharmacy and Pharmacology, 56 (6). pp. 691-702. ISSN 0022-3573 doi: 10.1211/0022357023619

Abstract/Summary

In recent years there has been a resurgence of interest in the biological roles of carbohydrates and as a result it is now known that carbohydrates are involved in a vast array of disease processes. This review summarises progress in the development of carbohydrate-based therapeutics that involve: inhibition of carbohydrate-lectin interactions; immunisation, using monoclonal antibodies for carbohydrate antigens; inhibition of enzymes that synthesise disease-associated carbohydrates; replacement of carbohydrate-processing enzymes; targeting of drugs to specific disease cells via carbohydrate-lectin interactions; carbohydrate based anti-thrombotic agents.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/11540
Identification Number/DOI 10.1211/0022357023619
Refereed Yes
Divisions Life Sciences > School of Chemistry, Food and Pharmacy > Department of Chemistry
Uncontrolled Keywords PHASE OLIGOSACCHARIDE SYNTHESIS, GLYCOSIDASE INHIBITORS, CAPSULAR, POLYSACCHARIDE, ADVANCED MALIGNANCIES, CLINICAL-APPLICATIONS, ANTIINFECTIVE AGENTS, TUMOR-METASTASIS, ANTICANCER DRUGS, CANCER, VACCINES, CELLS
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar